Boehringer Ingelheim Gives $65M to JGU Mainz for Life Sciences | GenomeWeb

NEW YORK (GenomeWeb News) – The Johannes Gutenberg University Mainz will receive €50 million ($65.4 million) over the next 10 years from the Boehringer Ingelheim Foundation to fund its life sciences activities, the university said on Friday.

The funding will go toward efforts to consolidate JGU's biology program around its Institute of Molecular Biology.

The IMB was established with €100 million in funding from the foundation in 2009, and now JGU said plans for this institute to serve as the basis of its biology activities and faculty.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.